Annals of Oncology

introduction:

Guest Editors:
Ann Oncol 17: v1-v2; doi:10.1093/annonc/mdl991 [PDF]

G. Cartei and R. Labianca

Introduction
Ann Oncol 17: v5-v6; doi:10.1093/annonc/mdj940 [PDF]

pharmacology and combinability of gemcitabine:

E. Mini, S. Nobili, B. Caciagli, I. Landini, and T. Mazzei

Cellular pharmacology of gemcitabine
Ann Oncol 17: v7-v12; doi:10.1093/annonc/mdj941 [Abstract] [PDF]

R. Rosell, M. Cobo, D. Isla, C. Camps, and B. Massuti

Pharmacogenomics and gemcitabine
Ann Oncol 17: v13-v16; doi:10.1093/annonc/mdj942 [Abstract] [PDF]

E. Giovannetti, R. Danesi, V. Mey, S. Nannizzi, G. Pasqualetti, and M. Del Tacca

In vitro studies on gemcitabine combinations with other antiblastics
Ann Oncol 17: v17-v19; doi:10.1093/annonc/mdj943 [Abstract] [PDF]

S. N. Richter, G. Cartei, M. Nadai, A. Trestin, L. Barzon, M. Palumbo, and G. Palù

In vitro basis for schedule-dependent interaction between gemcitabine and topoisomerase-targeted drugs in the treatment of colorectal cancer
Ann Oncol 17: v20-v24; doi:10.1093/annonc/mdj944 [Abstract] [PDF]

G. Cartei, A. Trestin, E. Colombrino, M. Nadai, S. N. Richter, L. Barzon, G. Palù, and M. Palumbo Of the Padua Pharmacology Oncology Group (PPOG)

Topoisomerase I, II and IIß mRNA expression in peripheral blood mononuclear cells of patients with solid tumor: preliminary results
Ann Oncol 17: v25-v28; doi:10.1093/annonc/mdj945 [Abstract] [PDF]

A. A. Adjei

Clinical studies of pemetrexed and gemcitabine combinations
Ann Oncol 17: v29-v32; doi:10.1093/annonc/mdj946 [Abstract] [PDF]

thoracic cancer:

R. P. Abratt and G. J. Hart

10-year update on chemotherapy for non-small cell lung cancer
Ann Oncol 17: v33-v36; doi:10.1093/annonc/mdj947 [Abstract] [PDF]

G. Metro, F. Cappuzzo, G. Finocchiaro, L. Toschi, and L. Crinò

Development of gemcitabine in non-small cell lung cancer: the Italian contribution
Ann Oncol 17: v37-v46; doi:10.1093/annonc/mdj948 [Abstract] [PDF]

G. Cartei, S. Binato, C. Sacco, A. Bearz, S. Scalone, R. Ceravolo, S. Cingarlini, U. Fantoni, A. Palamidese, A. Iop, and E. Colombrino

Simplified gemcitabine and platin regimen in patients with advanced or metastatic non-small cell lung cancer (NSCLC) to be proposed as neoadjuvant therapy
Ann Oncol 17: v47-v51; doi:10.1093/annonc/mdj949 [Abstract] [PDF]

L. Trodella, R. M. D'Angelillo, S. Ramella, F. Cellini, M. Ciresa, A. Cesario, and P. Granone

Chemo-radiotherapy in non-small cell lung cancer: the role of gemcitabine
Ann Oncol 17: v52-v54; doi:10.1093/annonc/mdj950 [Abstract] [PDF]

A. Santo, G. Genestreti, T. Sava, P. Manno, A. Terzi, A. M. Molino, and G. L. Cetto

Neo-adjuvant chemotherapy in non-small cell lung cancer (NSCLC)
Ann Oncol 17: v55-v61; doi:10.1093/annonc/mdj951 [PDF]

G. V. Scagliotti and S. Novello

Current status of adjuvant chemotherapy in NSCLC
Ann Oncol 17: v62-v63; doi:10.1093/annonc/mdj952 [PDF]

M. Rinaldi, C. Cauchi, and C. Gridelli

First line chemotherapy in advanced or metastatic NSCLC
Ann Oncol 17: v64-v67; doi:10.1093/annonc/mdj953 [Abstract] [PDF]

F. De Marinis, S. De Santis, and L. De Petris

Second-line chemotherapy for non-small cell lung cancer
Ann Oncol 17: v68-v71; doi:10.1093/annonc/mdj954 [Abstract] [PDF]

C. Gridelli, P. Maione, A. Rossi, C. Guerriero, C. Ferrara, F. Del Gaizo, G. Colantuoni, D. Nicolella, and L. Napolitano

Chemotherapy of advanced NSCLC in special patient population
Ann Oncol 17: v72-v78; doi:10.1093/annonc/mdj955 [Abstract] [PDF]

C. Boni, F. Zanelli, M. Ambroggi, and A. Bologna

Non-small-cell lung cancer: which platinum for gemcitabine?
Ann Oncol 17: v79-v81; doi:10.1093/annonc/mdj956 [PDF]

A. G. Favaretto

Non-platinum combination of gemcitabine in NSCLC
Ann Oncol 17: v82-v85; doi:10.1093/annonc/mdj957 [PDF]

C. Monnerat and T. Le Chevalier

Review of the pemetrexed and gemcitabine combination in patients with advanced-stage non-small cell lung cancer
Ann Oncol 17: v86-v90; doi:10.1093/annonc/mdj958 [Abstract] [PDF]

A. Ardizzoni and M. Tiseo

Novel targeted approaches in non-small cell lung cancer (NSCLC)
Ann Oncol 17: v91-v93; doi:10.1093/annonc/mdj959 [PDF]

F. Sartori, L. Bortolotti, G. Marulli, G. Rizzardi, A. Favaretto, A. Zuin, C. Breda, and F. Rea

The surgeon and the oncologist in non-small cell lung cancer (NSCLC)
Ann Oncol 17: v94-v98; doi:10.1093/annonc/mdj960 [Abstract] [PDF]

G. Rosti, O. Carminati, M. Monti, S. Tamberi, and M. Marangolo

Chemotherapy advances in small cell lung cancer
Ann Oncol 17: v99-v102; doi:10.1093/annonc/mdj961 [Abstract] [PDF]

M. Marangolo and B. Vertogen

Pemetrexed and malignant pleural mesothelioma
Ann Oncol 17: v103-v105; doi:10.1093/annonc/mdj962 [Abstract] [PDF]

bladder and renal cancer:

D. S. Kaufman

Challenges in the treatment of bladder cancer
Ann Oncol 17: v106-v112; doi:10.1093/annonc/mdj963 [Abstract] [PDF]

J. Bellmunt, S. Albiol, A. Ramírez de Olano, J. Pujadas, and P. Maroto On behalf the Spanish Oncology Genitourinary Group (SOGUG)

Gemcitabine in the treatment of advanced transitional cell carcinoma of the urothelium
Ann Oncol 17: v113-v117; doi:10.1093/annonc/mdj964 [Abstract] [PDF]

J. T. Roberts, H. von der Maase, L. Sengeløv, P. F. Conte, L. Dogliotti, T. Oliver, M. J. Moore, A. Zimmermann, and M. Arning

Long-term survival results of a randomized trial comparing gemcitabine/cisplatin and methotrexate/vinblastine/doxorubicin/cisplatin in patients with locally advanced and metastatic bladder cancer
Ann Oncol 17: v118-v122; doi:10.1093/annonc/mdj965 [Abstract] [PDF]

P. Gontero and B. Frea

Actual experience and future development of gemcitabine in superficial bladder cancer
Ann Oncol 17: v123-v128; doi:10.1093/annonc/mdj966 [Abstract] [PDF]

F. Boccardo and L. Palmeri

Adjuvant chemotherapy of bladder cancer
Ann Oncol 17: v129-v132; doi:10.1093/annonc/mdj967 [Abstract] [PDF]

F. Zustovich, G. Cartei, M. Dal Bianco, L. De Zorzi, R. Ceravolo, S. Zovato, F. Salmaso, S. Binato, G. Artioli, S. Cingarlini, and D. Pastorelli

A phase II study of Gemcitabine and immunotherapy in renal cancer: preliminary results and review of the literature
Ann Oncol 17: v133-v136; doi:10.1093/annonc/mdj968 [PDF]

gastrointestinal tumors:

R. Labianca, E. Berardi, and F. Malugani

Challenges in the treatment of gastrointestinal tumours
Ann Oncol 17: v137-v141; doi:10.1093/annonc/mdj969 [Abstract] [PDF]

L. Cattel, M. Airoldi, L. Delprino, R. Passera, P. Milla, and F. Pedani

Pharmacokinetic evaluation of gemcitabine and 2',2'-difluorodeoxycytidine-5'-triphosphate after prolonged infusion in patients affected by different solid tumors
Ann Oncol 17: v142-v147; doi:10.1093/annonc/mdj970 [Abstract] [PDF]

S. Cascinu, L. Verdecchia, N. Valeri, R. Berardi, and M. Scartozzi

New target therapies in advanced pancreatic cancer
Ann Oncol 17: v148-v152; doi:10.1093/annonc/mdj971 [Abstract] [PDF]

D. Pastorelli, G. Cartei, F. Zustovich, F. Marchese, G. Artioli, S. Zovato, S. Binato, R. Ceravolo, S. Cingarlini, F. Salmaso, M. Mattiazzi, C. Sanavio, F. Farinati, G. Zanus, and U. Cillo

Gemcitabine and liposomal doxorubicin in biliary and hepatic carcinoma (HCC) chemotherapy: preliminary results and review of the literature
Ann Oncol 17: v153-v157; doi:10.1093/annonc/mdj972 [Abstract] [PDF]

breast cancer:

M. Maur, V. Guarneri, A. Frassoldati, and P. F. Conte

Primary systemic therapy in operable breast cancer: clinical data and biological fall-out
Ann Oncol 17: v158-v164; doi:10.1093/annonc/mdj973 [Abstract] [PDF]

P. Pronzato and M. Rondini

First line chemotherapy of metastatic breast cancer
Ann Oncol 17: v165-v168; doi:10.1093/annonc/mdj974 [Abstract] [PDF]

E. Ferrazzi and L. Stievano

Gemcitabine: monochemotherapy of breast cancer
Ann Oncol 17: v169-v172; doi:10.1093/annonc/mdj975 [Abstract] [PDF]

D. Amadori and L. Cecconetto

Gemcitabine and taxanes in metastatic breast cancer
Ann Oncol 17: v173-v176; doi:10.1093/annonc/mdj976 [PDF]

P. Morandi

Biological agents and gemcitabine in the treatment of breast cancer
Ann Oncol 17: v177-v180; doi:10.1093/annonc/mdj977 [PDF]

ovarian cancer:

R. F. Ozols

Challenges for chemotherapy in ovarian cancer
Ann Oncol 17: v181-v187; doi:10.1093/annonc/mdj978 [Abstract] [PDF]

D. Lorusso, A. Di Stefano, F. Fanfani, and G. Scambia

Role of gemcitabine in ovarian cancer treatment
Ann Oncol 17: v188-v194; doi:10.1093/annonc/mdj979 [Abstract] [PDF]

E. Galligioni, C. Arcuri, R. Sorio, and C. Griso

Gemcitabine and anthracyclines in platinum-resistant ovarian cancer
Ann Oncol 17: v195-v198; doi:10.1093/annonc/mdj980 [Abstract] [PDF]

G. Scarfone and G. Bolis

Multimodal approach to ovarian cancer
Ann Oncol 17: v199-v200; doi:10.1093/annonc/mdj981 [PDF]

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.